Siga Technologies (SIGA) Change in Receivables (2010 - 2025)
Siga Technologies (SIGA) posted Change in Receivables of -$4.0 million for Q3 2025, down 471.61% on a QoQ basis from -$699108.0 in Q2 2025, and down 227.49% year-over-year from $3.1 million in Q3 2024.
Siga Technologies (SIGA) Change in Receivables (2010 - 2025) Analysis & Trends
Siga Technologies' Change in Receivables history runs 16 years deep, the most recent figure standing at -$4.0 million for Q3 2025.
- Quarterly Change in Receivables fell 227.49% year-over-year to -$4.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$9.6 million (down 337.66% YoY) and the FY2024 annual result came in at $35178.0, up 100.14% from the prior year.
- Change in Receivables was -$4.0 million for Q3 2025 at Siga Technologies, down from -$699108.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $79.8 million in Q4 2021 and bottomed at -$78.3 million in Q1 2022.
- A 5-year average of -$44738.4 and a median of -$699108.0 in 2025 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 1144.17% in 2022, while the deepest fall reached 11947.51% in 2022.
- Siga Technologies' Change in Receivables stood at $79.8 million in 2021, then tumbled by 111.92% to -$9.5 million in 2022, then soared by 237.42% to $13.1 million in 2023, then plunged by 30.61% to $9.1 million in 2024, then slumped by 144.02% to -$4.0 million in 2025.
- Business Quant data shows SIGA's Change in Receivables at -$4.0 million in Q3 2025, -$699108.0 in Q2 2025, and -$14.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4.00 Mn |
| Sep 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -699,108.00 |
| Jun 30, 2025 | -699,108.00 |
| Mar 31, 2025 | -13.98 Mn |
| Mar 31, 2025 | -13.98 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | -9.17 Mn |
| Jun 30, 2024 | -9.17 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | -6.29 Mn |
| Jun 30, 2023 | -6.29 Mn |